Shane Christian Mangrum
Physician in Idaho Falls, ID

2011029, Dec 1, 2011

Feb 1, 2011

13/019037

Shane MANGRUM - Ammon ID, US
Daniel Rogers BURNETT - San Francisco CA, US

TheraNova, LLC - San Francisco CA

A61H 9/00

601152

Devices that employ external compression stocking-type garments in the treatment of edema, chronic wounds, deep venous thrombosis prevention or claudication all share a number of significant limitations. These include the frequent need for custom fitting to assure an appropriate fit, vigilant maintenance to assure a continued “good fit,” limited compliance with proper use by patients and difficulty of application. There is a large body of evidence demonstrating that patients often decline to wear the compressive stockings as prescribed or in the form that would be most beneficial because they find these devices to be difficult to put on and take off. Building on the limitations of existing therapies, and distilled lessons learned from the field of prosthetics and wound healing, the present invention employs vacuum-assisted negative pressure to provide compression and help pump fluid from the tissues of affected limbs. The device is embodied in the form of a flexible stocking-like garment that will utilize a pumping mechanism to generate negative pressure around the limb and thus create vacuum compression that will mobilize fluid in a limb and increase venous return to the heart. Through the use of a circumferential wrap, the present invention provides a major advance in both the distribution of vacuum and the securing of the device over the limb.

7850704, Dec 14, 2010

Sep 26, 2005

11/234802

Daniel Rogers Burnett - San Francisco CA, US
Shane Mangrum - Ammon ID, US

TheraNova, LLC - San Francisco CA

A61B 17/08

606153

Methods, devices and systems facilitate retention of a variety of therapeutic devices. Devices generally include an anchoring element, which has been designed to promote fibrotic ingrowth, and an anchored device, which has been designed to firmly engage the complementary region of the anchoring element. The anchoring element may be placed in a minimally invasive procedure temporally separated from the deployment of the anchored device. Once enough time has passed to ensure appropriate fixation of the anchoring element by tissue and cellular ingrowth at the site of placement, the anchored device may then be deployed during which it firmly engages the complementary region of the anchoring element. In this manner, a firm attachment to the implantation site may be made with a minimum of required hardware. Some embodiments are delivered through a delivery tube or catheter and while some embodiments may require laparoscopy or open surgery for one or more of the placement procedures.

2009003, Jan 29, 2009

Aug 15, 2008

12/192462

Daniel Rogers BURNETT - San Francisco CA, US
Shane MANGRUM - Ammon ID, US

TheraNova, LLC - San Francisco CA

A61B 17/00, A61B 17/08, A61F 2/04, A61F 2/24

606153, 606151, 623 136, 623 238

Methods, devices and systems facilitate retention of a variety of therapeutic devices. Devices generally include an anchoring element, which has been designed to promote fibrotic ingrowth, and an anchored device, which has been designed to firmly engage the complementary region of the anchoring element. The anchoring element may be placed in a minimally invasive procedure temporally separated from the deployment of the anchored device. Once enough time has passed to ensure appropriate fixation of the anchoring element by tissue and cellular ingrowth at the site of placement, the anchored device may then be deployed during which it firmly engages the complementary region of the anchoring element. In this manner, a firm attachment to the implantation site may be made with a minimum of required hardware. Some embodiments are delivered through a delivery tube or catheter and while some embodiments may require laparoscopy or open surgery for one or more of the placement procedures. Some embodiments anchor devices within the cardiovascular tree while others may anchor devices within the gastrointestinal, peritoneal, pleural, pulmonary, urogynecologic, nasopharyngeal or dermatologic regions of the body. An alternative embodiment provides for the placement of the anchoring element and anchored device simultaneously, but allows for their removal separately. This embodiment allows the device, which may be placed only temporarily and be designed to be removed, to experience significant fibrotic ingrowth, but then to be easily detached from the ingrowth-anchored region to allow for simple and quick device removal.

2010022, Sep 2, 2010

Jan 27, 2010

12/695087

Shane MANGRUM - Ammon ID, US
Daniel BURNETT - San Francisco CA, US

EMKINETICS, INC. - Santa Cruz CA

A61N 2/04, A61N 2/02

600 14, 600 13

Current treatment options for Overactive Bladder and Urinary Incontinence include exercise and behavioral modifications, pharmacological therapies, surgical intervention, and neuromodulation. Although each of these treatments is used in the treatment of individuals with these conditions, each has severe limitations. Building on the limitations of existing therapies, and with the distillation of lessons learned from the field of pulsed electric stimulation, the present invention employs Low Frequency Induction Therapy for the delivery of an effective, cost efficient, noninvasive alternative to available treatment options. The device of the present application allows for consistent, user-friendly modulation of the pudendal nerve and the sacral plexus, via pulsed electromagnetic stimulation of the posterior tibial nerve, on an outpatient basis. The device has two primary components: a programmable Logic Controller (LC), which generates the required current, and a Conductive Wrap (CW), through which the current is channeled in generating the pulsed electromagnetic fields.

7597101, Oct 6, 2009

Jan 17, 2006

11/332799

Daniel Rogers Burnett - San Francisco CA, US
Shane Mangrum - Ammon ID, US

TheraNova, LLC - San Francisco CA

A61M 11/00

12820418

The present invention may create and maintain a pressure differential in the vicinity of the user's nasopharynx. A portable filter and pressurized air source subjects the region of the user's nasopharynx to positive or negative pressured air. Positive pressure prevents exposure to surrounding air while negative pressure isolates those around the user from potential toxins or pathogens exhaled from the user. With positive pressure, surrounding air is displaced preventing exposure to ambient air in most instances. With negative pressure, exhaled air is evacuated from the nasopharynx, filtered and returned to the user's surroundings to prevent exposure to those around the user. Such devices may be incorporated into garments, accessories or existing isolation devices (e. g. , face masks) to improve efficacy. Alternatively, the device may also be attached to an air source in the user's vicinity and provide filtration of the air prior to delivery to the region surrounding the user.

2007016, Jul 19, 2007

Jan 17, 2006

11/332797

Shane Mangrum - Ammon ID, US
Daniel Burnett - San Francisco CA, US

THERANOVA, LLC - San Francisco CA

A61N 1/00

607040000

Current treatment options for Overactive Bladder and Urinary Incontinence include exercise and behavioral modifications, pharmacological therapies, surgical intervention, and neuromodulation. Although each of these treatments is used in the treatment of individuals with these conditions, each has severe limitations. Building on the limitations of existing therapies, and with the distillation of lessons learned from the field of pulsed electric stimulation, the present invention employs Low Frequency Induction Therapy for the delivery of an effective, cost efficient, noninvasive alternative to available treatment options. The device of the present application allows for consistent, user-friendly modulation of the pudendal nerve and the sacral plexus, via pulsed electromagnetic stimulation of the posterior tibial nerve, on an outpatient basis. The device has two primary components: a programmable Logic Controller (LC), which generates the required current, and a Conductive Wrap (CW), through which the current is channeled in generating the pulsed electromagnetic fields.

2007010, May 10, 2007

Oct 23, 2006

11/552090

Daniel Burnett - San Francisco CA, US
Shane Mangrum - Idaho Falls ID, US
Jared Blanton - Mill Valley CA, US

Ceeben Systems, Inc. - Mill Valley CA

A61M 31/00

604508000, 604113000, 604006130, 604006160

Embodiments of the invention provide apparatus, systems and methods for introducing fluids into a body cavity for hypothermic, resuscitative, or other treatment. One embodiment provides an apparatus for introducing fluids into a peritoneal cavity comprising an access device for insertion into subcutaneous tissue, an infusion member and an advancement member. The access device includes a lumen, a proximal end, a tissue penetrating distal end and a stop for controlling the depth of the distal end into tissue. The infusion member includes an infusion lumen, a removal lumen and at least one sensor and is advanceable from a lumen of the access device into the peritoneal cavity. The advancement member is removably positionable in an infusion member lumen and has sufficient column strength to advance the infusion member tip through abdominal wall tissue into the peritoneal cavity. When the advancement member is removed, the infusion member tip is substantially atraumatic.

2007009, Apr 26, 2007

Jan 17, 2006

11/332796

Daniel Burnett - San Francisco CA, US
Shane Mangrum - Ammon ID, US

THERANOVA, LLC - San Francisco CA

A61B 5/00

600309000

The present invention provides a rapid, economical test for the detection of a right to left shunt applicable to the population at large due to its safety and noninvasiveness. The intended procedure involves gaining access to the circulatory system, injecting a measurable substance, ideally during prolonged and/or repeated Valsalva maneuvers, and then rapidly and repeatedly, ideally continuously, assaying for the substance. Through the determination of the appearance of a small amount of the substance prior to the subsequent high concentrations generated by the remainder of the bolus, one may safely diagnose a meaningful communication between the right and left heart, or other right to left shunt bypassing the lungs.